S312: IS BREXUCABTAGENE AUTOLEUCEL A COST-EFFECTIVE TREATMENT FOR REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA? A PHARMACOECONOMIC ANALYSIS IN THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM.
| Published in: | HemaSphere |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968160.75533.11 |